We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMC icon
276
Omnicom Group
OMC
$23.5B
$6.21M 0.08%
69,093
-13,624
-16% -$1.02M
ENTA icon
277
Enanta Pharmaceuticals
ENTA
$370M
$6.21M 0.08%
65,000
+3,000
+5% +$269K
F icon
278
Ford
F
$58.5B
$6.16M 0.08%
413,301
+13,679
+3% +$117K
TRP icon
279
TC Energy
TRP
$71.2B
$6.1M 0.08%
135,710
+5,076
+4% +$218K
RDUS
280
DELISTED
Radius Health, Inc.
RDUS
$6.06M 0.08%
304,025
– –
ROP icon
281
Roper Technologies
ROP
$37.1B
$6.01M 0.08%
17,581
+876
+5% +$266K
MS icon
282
Morgan Stanley
MS
$337B
$5.99M 0.08%
141,869
-153,484
-52% -$6.46M
OKE icon
283
Oneok
OKE
$56.4B
$5.97M 0.08%
85,432
+4,262
+5% +$276K
MAR icon
284
Marriott International
MAR
$101B
$5.96M 0.08%
39,683
+4,345
+12% +$511K
CF icon
285
CF Industries
CF
$18.4B
$5.92M 0.08%
144,689
+6,701
+5% +$284K
TGT icon
286
Target
TGT
$63.7B
$5.86M 0.08%
65,053
-16,174
-20% -$1.18M
TU icon
287
Telus
TU
$16.2B
$5.85M 0.07%
315,790
+46,190
+17% +$816K
GLW icon
288
Corning
GLW
$123B
$5.84M 0.07%
176,383
+107,941
+158% +$3.54M
RSG icon
289
Republic Services
RSG
$66.7B
$5.76M 0.07%
38,673
+898
+2% +$69.2K
NSC icon
290
Norfolk Southern
NSC
$77.1B
$5.76M 0.07%
26,801
+564
+2% +$97.5K
ETFC
291
DELISTED
E*Trade Financial Corporation
ETFC
$5.75M 0.07%
123,944
+107,242
+642% +$5.11M
FLIR
292
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$5.72M 0.07%
120,151
-54,342
-31% -$2.63M
VEEV icon
293
Veeva Systems
VEEV
$31.6B
$5.69M 0.07%
44,863
+1,297
+3% +$146K
DG icon
294
Dollar General
DG
$27.2B
$5.66M 0.07%
47,430
-46,352
-49% -$5.39M
D icon
295
Dominion Energy
D
$61.8B
$5.64M 0.07%
73,601
+2,065
+3% +$151K
SU icon
296
Suncor Energy
SU
$75.6B
$5.58M 0.07%
172,226
-2,347
-1% -$76.4K
SPGI icon
297
S&P Global
SPGI
$130B
$5.57M 0.07%
26,464
+477
+2% +$92.4K
PXD
298
DELISTED
Pioneer Natural Resource Co.
PXD
$5.57M 0.07%
36,592
+8,714
+31% +$1.23M
TGTX icon
299
TG Therapeutics
TGTX
$8.53B
$5.56M 0.07%
692,000
– –
ETR icon
300
Entergy
ETR
$53.1B
$5.54M 0.07%
115,796
+54,650
+89% +$2.47M
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.